In August, OCRA hosted a listening session with the U.S. Food and Drug Administration (FDA) to better understand the impact of Covid-19 on clinical trial participation.
Watch the full FDA listening session in the video below.
Related Topics
Wrapped in Love and Kelly Ripa Launch Limited-Edition Socks to Benefit OCRA
This September, Wrapped in Love has teamed up with multiple Emmy Award-winning talk show host, producer, New York Times Best Selling Author and actress Kelly Ripa to release a Limited-Edition Sock for Ovarian Cancer … Continued
The Overview: August 2025
September is Ovarian and Gynecologic Cancer Awareness Month — a time for our community to unite, raise awareness, and push forward in the search for better treatments and cures. As … Continued
September is Gynecologic and Ovarian Cancer Awareness Month
About Gynecologic Cancer Awareness Month September is recognized nationwide as Gynecologic Cancer Awareness Month. This is a dedicated time to raise awareness for all gynecologic cancers, including ovarian, cervical, uterine, … Continued